NCT05550129View on ClinicalTrials.gov

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

AMG 510

Oral tablet

DRUG

Metformin

Oral tablet

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT05550129 - Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants | Biotech Hunter | Biotech Hunter